JNJ

Equity

Johnson & Johnson

Health Care · Drug Manufacturers - General

$248.43

+248.43 (+0.00%)

Open

N/A

Day Range

$242.50 - $248.94

52W Range

$141.50 - $248.94

Volume

16M

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Latest News

J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold?

Zacks 8 hours ago

2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash

Motley Fool 12 hours ago

Johnson And Johnson Faces Fresh Talc Verdict As Pipeline Story Evolves

Simply Wall St. 23 hours ago

Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer

PR Newswire 1 day ago

Are You Looking for a High-Growth Dividend Stock?

Zacks 2 days ago

Fair Value Estimate

DDM Value

$107.45

131.2% overvalued

Growth: 4.9% | Req. return: 10%

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
001540.KQ AHN-GOOK PHA $8,070.00 N/A 5.45% +0.00%
ABT Abbott Laboratories $116.33 N/A 2.06% +0.00%
LLY Eli Lilly and Company $1,044.85 N/A 0.60% +0.00%
NVO Novo Nordisk A/S $37.41 N/A 4.50% +0.00%
EJG.F EBOS Group Ltd. R $11.70 N/A 5.14% +0.00%
0332.KL TOPVISN $0.17 N/A 11.76% +0.00%
5889.T JAPAN EYEWEAR HOLDINGS CO LTD $1,998.00 N/A 4.20% +0.00%
ABBV AbbVie Inc. $230.81 N/A 2.88% +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

www.jnj.com →

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

60

Safe

Based on 4 fundamental factors

+ 9 years of growth

Analysis Tools

Sign in for analysis tools

Share